Skip to main content
. 2020 May 19;11:2493. doi: 10.1038/s41467-020-16323-4

Fig. 4. Modeling the oncogenic mutations in in vitro-cultured stem cells.

Fig. 4

a The number of oncogenic mutations as a function of the number of in vitro-produced cells. b The probability of oncogenic mutations (x-axis) as a function of the number of in vitro-produced ASCs (primary y-axis,) and as a function of years of adult life (secondary y-axis). c The probability of BRAFV600E mutations (x-axis) as a function of the number of in vitro-produced ASCs (primary y-axis), and as a function of years of adult life (secondary y-axis).